Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects
暂无分享,去创建一个
Edwin Cuppen | Marcel Nelen | Wilfred F J van IJcken | Isaac J Nijman | Christel E M Kockx | Derek Butler | Erik Sistermans | Adalberto Costessi | Marjolein Kriek | Quinten Waisfisz | Martijn Vermaat | Jan D H Jongbloed | W. V. van IJcken | J. Veltman | E. Cuppen | R. Hennekam | M. Nelen | R. Sinke | W. van Workum | R. Kamps | Q. Waisfisz | B. van der Zwaag | J. D. den Dunnen | M. Vermaat | J. de Ligt | I. Nijman | M. Vogel | B. de Koning | J. Saris | E. Sistermans | M. V. van Slegtenhorst | D. Halley | F. Sleutels | C. Kockx | G. Santen | M. Kriek | M. van den Hout | K. Kraaijeveld | M. Mannens | C. Ploem | J. Jongbloed | N. van der Stoep | O. Mook | A. van den Wijngaard | M. Elferink | L. Johansson | Joris A Veltman | Joep de Ligt | Bert van der Zwaag | Nienke van der Stoep | G. Claes | Marianne van Tienhoven | Wilbert van Workum | Bart de Koning | Rick Kamps | Gijs Santen | Raoul Hennekam | A. Costessi | Derek Butler | T. Vrijenhoek | E. Kranendonk | W. Dorlijn | Winfried van Eyndhoven | Steven van Hove | R. H. Lekanne dit Deprez | H. Lunstroo | M. Rijnen | M. van Tienhoven | Janneke Marjan Weiss | H. Ijntema | Johan den Dunnen | Richard Sinke | Arthur van den Wijngaard | Terry Vrijenhoek | Ken Kraaijeveld | Martin Elferink | Elcke Kranendonk | Godelieve Claes | Wim Dorlijn | Winfried van Eyndhoven | Dicky J J Halley | Mirjam C G N van den Hout | Steven van Hove | Lennart F Johansson | Ronald Lekanne Dit Deprez | Hans Lunstroo | Marcel Mannens | Olaf R Mook | Corrette Ploem | Marco Rijnen | Jasper J Saris | Marjon van Slegtenhorst | Frank Sleutels | Maartje Vogel | Janneke Marjan Weiss | Helger Ijntema | R. H. Lekanne Dit Deprez | W. V. van Ijcken | Elcke J Kranendonk | Marianne van Tienhoven | W. V. van Workum | Helger Ijntema | Wilbert A. T. van Workum
[1] Ton Feuth,et al. Diagnostic genome profiling in mental retardation. , 2005, American journal of human genetics.
[2] Isaac S. Kohane,et al. Technical desiderata for the integration of genomic data into Electronic Health Records , 2012, J. Biomed. Informatics.
[3] Francisco M. De La Vega,et al. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. , 2009, Genome research.
[4] S. Antonarakis,et al. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy , 2008, Human mutation.
[5] Kelly Schoch,et al. Clinical application of exome sequencing in undiagnosed genetic conditions , 2012, Journal of Medical Genetics.
[6] Roger D. Cox,et al. A Mouse Model for the Metabolic Effects of the Human Fat Mass and Obesity Associated FTO Gene , 2009, PLoS genetics.
[7] J. Veltman,et al. Genome and exome sequencing in the clinic: unbiased genomic approaches with a high diagnostic yield. , 2012, Pharmacogenomics.
[8] Loss-of-function mutations in SLC 30 A 8 protect against type 2 diabetes , 2014 .
[9] Gail Geller,et al. Public Expectations for Return of Results from Large-Cohort Genetic Research , 2008, The American journal of bioethics : AJOB.
[10] Bradley P. Coe,et al. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.
[11] Emily H Turner,et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.
[12] Pieter B. T. Neerincx,et al. The Genome of the Netherlands: design, and project goals , 2013, European Journal of Human Genetics.
[13] Joseph K. Pickrell,et al. A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.
[14] Eric D Green,et al. The Complexities of Genomic Identifiability , 2013, Science.
[15] Dawei Li,et al. The diploid genome sequence of an Asian individual , 2008, Nature.
[16] Pieter B. T. Neerincx,et al. Supplementary Information Whole-genome sequence variation , population structure and demographic history of the Dutch population , 2022 .
[17] S. Turner,et al. Real-time DNA sequencing from single polymerase molecules. , 2010, Methods in enzymology.
[18] Nilesh J Samani,et al. The personal genome—the future of personalised medicine? , 2010, The Lancet.
[19] Euan A Ashley,et al. Challenges in the clinical application of whole-genome sequencing , 2010, The Lancet.
[20] Q. Waisfisz,et al. Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients , 2013, Clinical genetics.
[21] Marc Via i García. An integrated map of genetic variation from 1,092 human genomes , 2012 .
[22] John Broxholme,et al. Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease , 2012, European Journal of Human Genetics.
[23] P. Stankiewicz,et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.
[24] Timothy B. Stockwell,et al. The Diploid Genome Sequence of an Individual Human , 2007, PLoS biology.
[25] Christian Gilissen,et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome , 2010, Nature Genetics.
[26] Jungsuk Kim,et al. Recent advances in nanopore sequencing , 2012, Electrophoresis.
[27] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[28] Thomas Meitinger,et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes , 2014, Nature Genetics.
[29] J. Veltman,et al. Challenges for implementing next-generation sequencing-based genome diagnostics: it's also the people, not just the machines. , 2013, Personalized medicine.
[30] H. Bayley,et al. Continuous base identification for single-molecule nanopore DNA sequencing. , 2009, Nature nanotechnology.
[31] Peter Kraft,et al. Re-Ranking Sequencing Variants in the Post-GWAS Era for Accurate Causal Variant Identification , 2013, PLoS genetics.
[32] D. Srivastava,et al. Genetics of Human Cardiovascular Disease , 2012, Cell.
[33] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[34] H. Mefford. Diagnostic exome sequencing--are we there yet? , 2012, The New England journal of medicine.
[35] J. Veltman,et al. De novo mutations in human genetic disease , 2012, Nature Reviews Genetics.
[36] Jeroen F. J. Laros,et al. LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.
[37] Quinten Waisfisz,et al. Best Practice Guidelines for the Use of Next‐Generation Sequencing Applications in Genome Diagnostics: A National Collaborative Study of Dutch Genome Diagnostic Laboratories , 2013, Human mutation.
[38] Christian Gilissen,et al. Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.
[39] Peter Pop,et al. Routine Individual Feedback on Requests for Diagnostic Tests , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.
[40] Christian Gilissen,et al. Next-generation genetic testing for retinitis pigmentosa , 2012, Human mutation.
[41] N. Hawkins,et al. Data sharing in genomics — re-shaping scientific practice , 2009, Nature Reviews Genetics.
[42] S. Mundlos,et al. The Human Phenotype Ontology , 2010, Clinical genetics.
[43] Jay Shendure,et al. Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia , 2010, Human molecular genetics.
[44] David P Bick,et al. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.
[45] M. Modell,et al. Raising the profile of genetics in primary care , 2004, Nature Reviews Genetics.
[46] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[47] J. Lupski,et al. The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.
[48] Raymond K. Auerbach,et al. The real cost of sequencing: higher than you think! , 2011, Genome Biology.
[49] C. Semsarian,et al. Multiple Mutations in Genetic Cardiovascular Disease: A Marker of Disease Severity? , 2009, Circulation. Cardiovascular genetics.
[50] Stef van Lieshout,et al. Dominant missense mutations in ABCC9 cause Cantú syndrome , 2012, Nature Genetics.
[51] Jane Kaye,et al. Implementing a successful data-management framework: the UK10K managed access model , 2013, Genome Medicine.
[52] Elaine R. Mardis,et al. A decade’s perspective on DNA sequencing technology , 2011, Nature.
[53] J. Shendure,et al. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data , 2011, Nature Reviews Genetics.
[54] J. Lupski,et al. Human genome sequencing in health and disease. , 2012, Annual review of medicine.
[55] Nicholas R. Hardiker,et al. Incorporating personalized gene sequence variants, molecular genetics knowledge, and health knowledge into an EHR prototype based on the Continuity of Care Record standard , 2012, J. Biomed. Informatics.
[56] Muin J Khoury,et al. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.
[57] Christian Gilissen,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, New England Journal of Medicine.
[58] P. Stenson,et al. The Human Gene Mutation Database: 2008 update , 2009, Genome Medicine.
[59] S. Turner,et al. Real-Time DNA Sequencing from Single Polymerase Molecules , 2009, Science.
[60] M. Ferber,et al. Expanding DNA diagnostic panel testing: is more better? , 2011, Expert review of molecular diagnostics.
[61] Dominique Stoppa-Lyonnet,et al. Evaluation of in silico splice tools for decision‐making in molecular diagnosis , 2008, Human mutation.
[62] Richard M Weinshilboum,et al. Genomics and drug response. , 2011, The New England journal of medicine.
[63] Nicholas Katsanis,et al. Molecular genetic testing and the future of clinical genomics , 2013, Nature Reviews Genetics.
[64] A. Sidow,et al. Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet–Biedl syndrome , 2010, Proceedings of the National Academy of Sciences.
[65] P. Shannon,et al. Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.
[66] L. Biesecker. Hypothesis-generating research and predictive medicine , 2013, Genome research.
[67] S. Levy,et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia , 2011, Nature Genetics.
[68] G. Church,et al. Public Access to Genome-Wide Data: Five Views on Balancing Research with Privacy and Protection , 2009, PLoS genetics.
[69] J. Hardy,et al. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease , 2012, Nature Reviews Neuroscience.
[70] W. Grody,et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.
[71] E. Mardis. The impact of next-generation sequencing technology on genetics. , 2008, Trends in genetics : TIG.